Acarbose presents in vitro and in vivo antileishmanial activity against Leishmania infantum and is a promising therapeutic candidate against visceral leishmaniasis.
Costa RR, Oliveira-da-Silva JA, Reis TAR, Tavares GSV, Mendonça DVC, Freitas CS, Lage DP, Martins VT, Antinarelli LMR, Machado AS, Bandeira RS, Ludolf F, Santos TTO, Brito RCF, Humbert MV, Menezes-Souza D, Duarte MC, Chávez-Fumagalli MA, Roatt BM, Coimbra ES, Coelho EAF.
Costa RR, et al. Among authors: duarte mc.
Med Microbiol Immunol. 2021 Jun;210(2-3):133-147. doi: 10.1007/s00430-021-00707-4. Epub 2021 Apr 18.
Med Microbiol Immunol. 2021.
PMID: 33870453
Free PMC article.